These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 37144371)
41. [Not Available]. Dalbro SEJ; Kerty E Tidsskr Nor Laegeforen; 2019 Sep; 139(13):. PubMed ID: 31556528 [TBL] [Abstract][Full Text] [Related]
42. Recurrent Optic Neuritis and Perineuritis Followed by an Unexpected Discovery: From the National Multiple Sclerosis Society Case Conference Proceedings. Pimentel Maldonado DA; Lisak R; Galetta S; Balcer L; Varkey T; Goodman A; Graves J; Racke M; Zamvil SS; Newsome S; Frohman EM; Frohman TC Neurol Neuroimmunol Neuroinflamm; 2023 Jan; 10(1):. PubMed ID: 36357190 [TBL] [Abstract][Full Text] [Related]
43. Treatment options for atypical optic neuritis. Malik A; Ahmed M; Golnik K Indian J Ophthalmol; 2014 Oct; 62(10):982-4. PubMed ID: 25449930 [TBL] [Abstract][Full Text] [Related]
44. Optical coherence tomography (OCT) in optic neuritis and multiple sclerosis. Lamirel C; Newman NJ; Biousse V Rev Neurol (Paris); 2010 Dec; 166(12):978-86. PubMed ID: 20605617 [TBL] [Abstract][Full Text] [Related]
45. Quantification of retinal neural loss in patients with neuromyelitis optica and multiple sclerosis with or without optic neuritis using Fourier-domain optical coherence tomography. Monteiro ML; Fernandes DB; Apóstolos-Pereira SL; Callegaro D Invest Ophthalmol Vis Sci; 2012 Jun; 53(7):3959-66. PubMed ID: 22589446 [TBL] [Abstract][Full Text] [Related]
46. Plasma exchange: an effective add-on treatment of optic neuritis in neuromyelitis optica spectrum disorders. Song W; Qu Y; Huang X Int Ophthalmol; 2019 Nov; 39(11):2477-2483. PubMed ID: 30825049 [TBL] [Abstract][Full Text] [Related]
48. Neuromyelitis optica diagnosis in clinically isolated syndromes suggestive of multiple sclerosis. Rubiera M; Río J; Tintoré M; Nos C; Rovira A; Téllez N; Montalban X Neurology; 2006 May; 66(10):1568-70. PubMed ID: 16717222 [TBL] [Abstract][Full Text] [Related]
49. [Inflammation of the optic nerve: when it should be considered as neuromyelitis optica--the experience of the Department of Neurology at Hadassah Hospital]. Vaknin-Dembinsky A; Levin N; Raz N; Abramsky O; Karussis D; Brill L; Petrou P; Ovadia H Harefuah; 2013 Feb; 152(2):101-5, 122. PubMed ID: 23513502 [TBL] [Abstract][Full Text] [Related]
50. Optic neuritis in the era of biomarkers. Chen JJ; Pittock SJ; Flanagan EP; Lennon VA; Bhatti MT Surv Ophthalmol; 2020; 65(1):12-17. PubMed ID: 31425702 [TBL] [Abstract][Full Text] [Related]
51. Brain and spinal cord lesion criteria distinguishes AQP4-positive neuromyelitis optica and MOG-positive disease from multiple sclerosis. Bensi C; Marrodan M; González A; Chertcoff A; Osa Sanz E; Chaves H; Schteinschnaider A; Correale J; Farez MF Mult Scler Relat Disord; 2018 Oct; 25():246-250. PubMed ID: 30144694 [TBL] [Abstract][Full Text] [Related]
59. Baseline demographics, clinical features, and treatment protocols of 240 patients with optic neuropathy: experiences from a neuro-ophthalmological clinic in the Aegean region of Turkey. Karti O; Karti DT; Kilic İH; Gokcay F; Celebisoy N Int Ophthalmol; 2019 Jan; 39(1):155-166. PubMed ID: 29260500 [TBL] [Abstract][Full Text] [Related]
60. [Differential diagnosis of optic neuritis (review]. Shmidt TE Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(9 Pt 2):5-9. PubMed ID: 23378987 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]